Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
<h4>Background</h4>Immunosuppressed individuals present serious morbidity and mortality from influenza, therefore it is important to understand the safety and immunogenicity of influenza vaccination among them.<h4>Methods</h4>This multicenter cohort study evaluated the immuno...
Guardado en:
Autores principales: | João L Miraglia, Edson Abdala, Paulo M Hoff, André M Luiz, Danise S Oliveira, Carla G S Saad, Ieda M M Laurindo, Ana T R Viso, Angela Tayra, Lígia C Pierrotti, Luiz S Azevedo, Lúcia Maria A Campos, Nádia E Aikawa, Maria do Carmo S T Timenetsky, Expedito Luna, Maria Regina A Cardoso, José da S Guedes, Isaias Raw, Jorge Kalil, Alexander R Precioso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a521253f5a8a48878f105bf9684f2625 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
por: M. K. Erofeeva, et al.
Publicado: (2014) -
Monovalent lanthanide(I) in borozene complexes
por: Wan-Lu Li, et al.
Publicado: (2021) -
Generalized pruritic skin eruption in an immunocompromised patient
por: Stephanie Wang, et al.
Publicado: (2014) -
Long-lasting, monovalent-selective capacitive deionization electrodes
por: Eric N. Guyes, et al.
Publicado: (2021) -
Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Waleed H. Mahallawi, et al.
Publicado: (2021)